Replacement of the retrohepatic inferior vena cava (IVC) after concurrent resection of IVC and hepatocellular carcinoma-containing liver is settled as a feasible living donor liver transplantation (LDLT) technique to cope with tumors around the IVC. This technique makes LDLT comparable to deceased-donor liver transplantation (DDLT). In the current Korean setting, the common substitute for IVC is a Dacron graft for adult recipients. In contrast, such a synthetic graft cannot be used for pediatric patients because of ongoing growth. We present one pediatric LDLT case with IVC homograft replacement for advanced hepatoblastoma. The patient was a 8 year-old boy suffering from large multiple hepatoblastomas. The tumors encroached the retrohepatic IVC. Thus there was high risk of residual tumor cells at the IVC, if it was preserved. Thus, we decided to replace IVC at the time of LDLT. After waiting for ＞1 month, we finally obtained cold-stored IVC homograft and LDLT was performed with the mother's left liver. A 4 cm-long IVC allograft was anastomosed at the back table. The left liver graft with IVC interposition was implanted along standard procedure similar to DDLT. The patient recovered uneventfully and is undergoing scheduled adjuvant chemotherapy. We have performed ＞20 cases of IVC replacement in adult recipients with hepatocellular carcinoma or Budd-Chiari syndrome, but all vessel substitutes were synthetic, because sizable IVC homograft is unavailable. In pediatric recipients, various vein homografts such as iliac vein, IVC and other large-sized veins, can be used depending on body size of recipient and availability of vessel grafts. 
INTRODUCTION

Replacement of the retrohepatic inferior vena cava (IVC)
after concurrent resection of IVC and hepatocellular carcinoma (HCC)-containing liver is settled as an optional technique of living donor liver transplantation (LDLT) to cope with HCCs around the IVC. [1] [2] [3] [4] This technique makes the resection extent of LDLT comparable to that of deceaseddonor liver transplantation (DDLT). In the current Korean setting, the common substitute for IVC is a Dacron graft for adult recipients. In contrast, such a synthetic graft cannot be used for pediatric patients because of ongoing physical growth. Thus, homograft should be used. There are only few cases on IVC replacement in pediatric LDLT. 5 We herein present one case of IVC replacement performed during pediatric LDLT to treat advanced hepatoblastoma.
CASE
The patient was an 8 year-old 28 Kg-weighing boy suffering from large multiple hepatoblastomas, partially responsive to systemic chemotherapy (Fig. 1) age, we waited until suitable large-sized vein allograft was available.
After waiting for more than one month, we finally ob- Recipient's native liver including the retrohepatic IVC was removed completely (Fig. 5) . The left liver graft with IVC interposition was implanted along standard procedure (Fig. 6 ). After completion of reconstruction, the potentially tumor-invaded right diaphragm was excised, and repaired primarily (Fig. 7) . Thereafter, indocyanine green (ICG)
fluorescent imaging was applied to identify any remaining tumor, in which no abnormal fluorescent image was detected.
Since the liver graft was relatively very small compared with the 2064 g-weighing tumor-bearing native liver, a tissue expander was placed to prevent rotation toward the right subphrenic fossa. The tissue expander was removed after 2 weeks (Fig. 8 ).
This patient recovered uneventfully and is doing well for 3 months to date. He is currently undergoing scheduled adjuvant chemotherapy.
DISCUSSION
Compared with DDLT, LDLT has a definite demerit on In the current Korean setting, the common substitute for IVC is Dacron graft for adult recipients. 6 This synthetic vessel institutes provides a large diameter, which exceeds the usual diameter of normal IVC, thus it is suitable for partial liver implantation. However, such a synthetic graft cannot be used for pediatric patients because of ongoing growth. There have been only few reports on IVC replacement in pediatric LDLT. 5 The biggest hindrance against IVC replacement is availability of sizable vein homograft in countries where pediatric LDLT is frequently performed but the incidence of deceased donors is not high.
After deciding to perform LDLT with IVC replacement in this case, we had to wait for more than one month to that no remnant tumor remained after resection. 7 We suggest injecting ICG dye intravenously more than 24 hours before operation, to make ICG accumulate at the tumor tissue.
In this case, the abdominal cavity was distended due to enlarged liver with large multiple tumors, but the liver graft was much smaller than the liver size. year-old pediatric patient with Budd-Chiari syndrome. 5 In conclusion, IVC replacement with homograft is a feasible option of LDLT in pediatric patients with advanced liver malignancies.
